PCSK9 and familial hypercholesterolemia: In addition, recent studies in patients with familial hypercholesterolemia suggest that beneficial effects of PCSK9 inhibitor therapy on sdLDL particles are associated with an improvement in endothelial function [31] and carotid stiffness [32].